FYI from the NHLBI Index

May 2011: Vol. 12, Issue 1
Feature Article



NHLBI Will Host the 12th Annual PIO Meeting

The NHLBI will hold its Twelfth Annual Public Interest Organization (PIO) meeting on May 23–24, 2011, at the Bethesda Marriott on Pooks Hill Road in Bethesda, Maryland. PIO attendees of the previous annual meetings have praised the events for providing unique opportunities to interact with other PIO representatives, to learn more about the NIH and the NHLBI, and to meet NIH and NHLBI leadership as well as NHLBI staff members.

The upcoming meeting, with its focus on timely, important topics, promises not to disappoint. This year’s meeting program will again encourage significant networking time with members of fellow PIOs as well as with NHLBI staff.

The meeting will begin Monday afternoon, May 23, with registration at 4 pm. At 5 pm, opening remarks will be followed by the keynote address delivered by Dr. Lawrence A. Tabak, Deputy Director, NIH.

On Tuesday, May 24, registration resumes at 7:30 am.

Tuesday’s program will begin at 8:30 am with a presentation by Dr. Susan B. Shurin, Acting Director, NHLBI, and will feature an array of speakers from PIOs, the NHLBI, and the NIH.

Following Dr. Shurin’s presentation, PIO representatives will have an opportunity to meet NHLBI staff members who have expertise in heart development and diseases, vascular diseases, lung diseases, airway diseases, blood diseases and resources, and sleep and sleep disorders. This portion of the meeting has been very well received in the past.

After lunch, the meeting will continue with presentations about the NIH Undiagnosed Diseases Program offered by Dr. Cynthia Tifft, Deputy Clinical Director, National Human Genome Research Institute, NIH, and Dr. Robert Balaban, Scientific Director, NHLBI.

A session on Dietary Supplements will be presented by Dr. Paul Coates, Director, Office of Dietary Supplements, NIH, and Ms. Caroline Kruse, Executive Director, Platelet Disorder Support Association.

The concluding session will focus on Collaboration, Resources, and Information Sharing and will be presented by Mr. James O’Leary, Chief Innovation Officer, Genetic Alliance, Dr. Stephen Groft, Director, Office of Rare Diseases Research, NIH, and Ms. Audrey Gordon, Executive Director, Progeria Research Foundation.

Modified 5/9/11
[Table of Contents]



Please send us your feedback, comments, and questions by using the appropriate link on the page, Contact the NHLBI.

Note to users of screen readers and other assistive technologies: please report your problems here.




Skip footer links and go to content
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon